BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 15640842)

  • 1. Polo-like kinases and oncogenesis.
    Eckerdt F; Yuan J; Strebhardt K
    Oncogene; 2005 Jan; 24(2):267-76. PubMed ID: 15640842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polo-like kinases and DNA damage checkpoint: beyond the traditional mitotic functions.
    Bahassi el M
    Exp Biol Med (Maywood); 2011 Jun; 236(6):648-57. PubMed ID: 21558091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polo-like kinases and the microtubule organization center: targets for cancer therapies.
    Dai W; Cogswell JP
    Prog Cell Cycle Res; 2003; 5():327-34. PubMed ID: 14593727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Getting in and out of mitosis with Polo-like kinase-1.
    van Vugt MA; Medema RH
    Oncogene; 2005 Apr; 24(17):2844-59. PubMed ID: 15838519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Sak polo-box comprises a structural domain sufficient for mitotic subcellular localization.
    Leung GC; Hudson JW; Kozarova A; Davidson A; Dennis JW; Sicheri F
    Nat Struct Biol; 2002 Oct; 9(10):719-24. PubMed ID: 12352953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues.
    Winkles JA; Alberts GF
    Oncogene; 2005 Jan; 24(2):260-6. PubMed ID: 15640841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma.
    Pellegrino R; Calvisi DF; Ladu S; Ehemann V; Staniscia T; Evert M; Dombrowski F; Schirmacher P; Longerich T
    Hepatology; 2010 Mar; 51(3):857-68. PubMed ID: 20112253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incomplete cytokinesis and induction of apoptosis by overexpression of the mammalian polo-like kinase, Plk3.
    Conn CW; Hennigan RF; Dai W; Sanchez Y; Stambrook PJ
    Cancer Res; 2000 Dec; 60(24):6826-31. PubMed ID: 11156373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polo-like kinases (Plks) and cancer.
    Takai N; Hamanaka R; Yoshimatsu J; Miyakawa I
    Oncogene; 2005 Jan; 24(2):287-91. PubMed ID: 15640844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of cell cycle checkpoints by polo-like kinases.
    Xie S; Xie B; Lee MY; Dai W
    Oncogene; 2005 Jan; 24(2):277-86. PubMed ID: 15640843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient internalization of the polo-box of polo-like kinase 1 fused to an Antennapedia peptide results in inhibition of cancer cell proliferation.
    Yuan J; Krämer A; Eckerdt F; Kaufmann M; Strebhardt K
    Cancer Res; 2002 Aug; 62(15):4186-90. PubMed ID: 12154015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yeast polo-like kinases: functionally conserved multitask mitotic regulators.
    Lee KS; Park JE; Asano S; Park CJ
    Oncogene; 2005 Jan; 24(2):217-29. PubMed ID: 15640837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-mitotic functions of polo-like kinases in cancer cells.
    Raab CA; Raab M; Becker S; Strebhardt K
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188467. PubMed ID: 33171265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Plk3 in oncogenesis.
    Helmke C; Becker S; Strebhardt K
    Oncogene; 2016 Jan; 35(2):135-47. PubMed ID: 25915845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polo-like kinases in the nervous system.
    Seeburg DP; Pak D; Sheng M
    Oncogene; 2005 Jan; 24(2):292-8. PubMed ID: 15640845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo tumor imaging using polo-box domain of polo-like kinase 1 targeted peptide.
    Kim SM; Yoon S; Choi N; Hong KS; Murugan RN; Cho G; Ryu EK
    Biomaterials; 2012 Oct; 33(29):6915-25. PubMed ID: 22795848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Plk3-Cdc25 circuit.
    Myer DL; Bahassi el M; Stambrook PJ
    Oncogene; 2005 Jan; 24(2):299-305. PubMed ID: 15640846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the Plk4/Sak consensus phosphorylation motif using peptide spots arrays.
    Leung GC; Ho CS; Blasutig IM; Murphy JM; Sicheri F
    FEBS Lett; 2007 Jan; 581(1):77-83. PubMed ID: 17174311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of high-throughput assays based on fluorescence polarization for inhibitors of the polo-box domains of polo-like kinases 2 and 3.
    Reindl W; Gräber M; Strebhardt K; Berg T
    Anal Biochem; 2009 Dec; 395(2):189-94. PubMed ID: 19716361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polo-like kinases: a team in control of the division.
    van de Weerdt BC; Medema RH
    Cell Cycle; 2006 Apr; 5(8):853-64. PubMed ID: 16627997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.